Isolation of peptides of the brevinin-1 family with potent candidacidal activity from the skin secretions of the frog Rana boylii

Journal of Peptide Research

Volumn 62, Issue 5, 2003, Pages 207-213

  Conlon, J M ^a   Sonnevend, A ^a   Patel, M ^a   Davidson, C ^b   Nielsen, P F ^c   Pal T ^a   Rollins Smith, L A ^d  

^a UNITED ARAB EMIRATES UNIVERSITY   (United Arab Emirates)

^b CALIFORNIA STATE UNIVERSITY   (United States)

^c NOVO NORDISK A S   (Denmark)

^d VANDERBILT UNIVERSITY   (United States)

Author keywords

Amphibian skin; Brevinin 1; Candida albicans; Rana; Ranatuerin 2; Temporin

Indexed keywords

ANTIFUNGAL AGENT; BREVININ 1; ISOLEUCINE; LEUCINE; LYSINE; NORADRENALIN; PHENYLALANINE; RANATUERIN 2; TEMPORIN; THREONINE; UNCLASSIFIED DRUG; VALINE;

AMINO ACID SUBSTITUTION; ANTIBIOTIC RESISTANCE; ANTIFUNGAL ACTIVITY; ANTIMICROBIAL ACTIVITY; ARTICLE; CANDIDA ALBICANS; ESCHERICHIA COLI; FROG; HEMOLYSIS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN ISOLATION; SKIN; SKIN SECRETION; STAPHYLOCOCCUS AUREUS;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; AMPHIBIAN PROTEINS; ANIMALS; ANTIFUNGAL AGENTS; ANTIMICROBIAL CATIONIC PEPTIDES; CANDIDA ALBICANS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; ERYTHROCYTES; ESCHERICHIA COLI; HUMANS; MASS SPECTROMETRY; MICROBIAL SENSITIVITY TESTS; MOLECULAR SEQUENCE DATA; RANIDAE; SKIN; STAPHYLOCOCCUS AUREUS; TIME FACTORS;

AMPHIBIA; ANURA; CANDIDA; CANDIDA ALBICANS; ESCHERICHIA COLI; RANA BOYLII; STAPHYLOCOCCUS; STAPHYLOCOCCUS AUREUS;

EID: 0242364776     PISSN: 1397002X     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-3011.2003.00090.x     Document Type: Article

References (39)

1. Reichart, P.A., Samaranayake, L.P. & Philipsen, H.P. (2000) Pathology and clinical correlates in oral candidiasis and its variants: a review. Oral Dis. 6, 85-91.
2. Jarvis, W.R. (1995) Epidemiology of nosocomial fungal infections, with emphasis on Candida species. Clin. Infect. Dis. 20, 1526-1530.
3. Taylor, B.N., Fichtenbaum, C., Saavedra, M., Slavinsky, J., Swoboda, R., Wozniak, K., Arribas, A., Powderly, W. & Fidel, P.L. (2000) In vivo virulence of Candida albicans isolates causing mucosal infections in people infected with the human immunodeficiency virus. J. Infect. Dis. 182, 955-959.
4. Tumbarello, M., Tacconelli, E., de Gaetano Donati, K., Morace, G., Fadda, G. & Cauda, R. (1999) Candidemia in HIV-infected subjects. Eur. J. Clin. Microbiol. Infect. Dis. 18, 478-483.
5. Sanglard, D., Kuchler, K., Ischer, F., Pagani, J.L., Monod, M. & Bille, J. (1995) Mechanisms of resistance to azole antifungal agents in Candida albicans isolates from AIDS patients involve specific multidrug transporters. Antimicrob. Agents Chemother. 39, 2378-2386.
6. White, T.C., Holleman, S., Dy, F., Mirels, L.F. & Stevens, D.A. (2002) Resistance mechanisms in clinical isolates of Candida albicans. Antimicrob. Agents Chemother. 46, 1704-1713.
7. Simmaco, M., Mignogna, G. & Barra, D. (1998) Antimicrobial peptides from amphibian skin: what do they tell us? Biopolymers 47, 435-450.
8. Hancock, R.E. & Chapple, D.S. (1999) Peptide antibiotics. Antimicrob. Agents. Chemother. 43, 1317-1323.
9. Rollins-Smith, L.A., Reinart, L.K., Miera, V. & Conlon, J.M. (2002) Antimicrobial peptide defenses of the Tarahumara frog, Rana tarahumarae. Biochem. Biophys. Res. Commun. 297, 361-367.
10. Morikawa, N., Hagiwara, K. & Nakajima, T. (1992) Brevinin-1 and -2, unique antimicrobial peptides from the skin of the frog, Rana brevipoda porsa. Biochem. Biophys. Res. Commun. 189, 184-190.
11. Sai, P.S., Jagannadham, V.J., Vairamani, M., Raju, N.P., Devi, A.S., Nagaraj, R. & Sitaram, N. (2001) Tigerinins: novel antimicrobial peptides from the Indian frog, Rana tigerina. J. Biol. Chem. 276, 2701-2707.
12. Isaacson, T., Soto, A., Iwamuro, S., Knoop, F.C. & Conlon, J.M. (2002) Antimicrobial peptides with atypical structural features from the skin of the Japanese brown frog Rana japonica. Peptides 23, 419-425.
13. Mor, A., Hani, K. & Nicolas, P. (1994) The vertebrate peptide antibiotics dermaseptins have overlapping structural features but target specific microorganisms. J. Biol. Chem. 269, 31635-31641.
14. Davidson, C., Shaffer, H.B. & Jennings M.R. (2002) Spatial tests of the pesticide drift, habitat destruction, UV-B, and climate change hypotheses for California amphibian declines. Conservation Biol. 16, 1588-1601.
15. Kupferberg, S.J. (1997) Bullfrog (Rana catesbeiana) invasion of a California river: the role of larval competition. Ecology 78, 1736-1751.
16. National Committee for Clinical Laboratory Standards (1993) Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically: Approved Standard M7-A3. NCCLS, Villanova, PA, USA.
17. Wade, D., Silveira, A., Silberring, J., Kuusela, P. & Lankinen, H. (2000) Temporin antibiotic peptides: a review and derivation of a consensus sequence. Protein Peptide Lett. 7, 349-357.
18. Goraya, J., Knoop, F.C. & Conlon, J.M. (1998) Ranatuerins: antimicrobial peptides isolated from the skin of the American bullfrog, Rana catesbeiana. Biochem. Biophys. Res. Commun. 250, 589-592.
19. Conlon, J.M., Halverson, T., Dulka, J., Platz, J.E. & Knoop, F.C. (1999) Peptides with antimicrobial activity of the brevinin-1 family isolated from skin secretions of the southern leopard frog, Rana sphenocephala. J. Peptide Res. 54, 522-527.
20. Goraya, J., Wang, Y., Li, Z., O'Flaherty, M., Knoop, F.C., Platz, J.E. & Conlon, J.M. (2000) Peptides with antimicrobial activity from four different families isolated from the skins of the North American frogs, Rana luteiventris, Rana berlandieri and Rana pipiens. Eur. J. Biochem. 267, 894-900.
21. Basir, Y.J., Knoop, F.C., Dulka, J. & Conlon, J.M. (2000) Multiple antimicrobial peptides and peptides related to bradykinin and neuromedin N isolated from the skin secretions of the North American pickerel frog, Rana palustris. Biochim. Biophys. Acta 1543, 95-105.
22. Matutte, B., Storey, K.B., Knoop, F.C. & Conlon, J.M. (2000) Induction of synthesis of an antimicrobial peptide in the skin of the freeze-tolerant frog, Rana sylvatica in response to environmental stimuli. FEBS Lett. 483, 135-138.
23. Ali, M.F., Lips, K.R., Knoop, F.C., Fritzsch, B., Miller, C. & Conlon, J.M. (2002) Antimicrobial peptides and protease inhibitors in the skin secretions of the crawfish frog, Rana areolata. Biochim. Biophys. Acta 1601, 55-63.
24. Simmaco, M., Mignogna, G., Barra, D. & Bossa, F. (1994) Antimicrobial peptides from skin secretions of Rana esculenta. J. Biol. Chem. 269, 11 956-11 961.
25. Yeaman, M.R. & Yount, N.Y. (2003) Mechanisms of antimicrobial peptide action and resistance. Pharmacol. Rev. 55, 27-55.
26. Kwon, M.-Y., Hong, S.Y. & Lee, K.H. (1998) Structure-activity analysis of brevinin 1E amide, an antimicrobial peptide from Rana esculenta. Biochim. Biophys. Acta 1387, 239-248.
27. Eisenberg, D. (1984) Three-dimensional structure of membrane and surface proteins. Annu. Rev. Biochem. 53, 595-623.
28. Dathe, M., Wieprecht, T., Nikolenko, H., Handel, L., Maloy, W.L., MacDonald, D.L., Beyermann, M. & Bienert, M. (1997) Hydrophobicity, hydrophobic moment and angle subtended by charged residues modulate antibacterial and haemolytic activity of amphipathic helical peptides. FEBS Lett. 403, 208-212.
29. Dathe, M. & Wieprecht, T. (1999) Structural features of helical antimicrobial peptides: their potential to modulate activity on model membranes and biological cells. Biochim Biophys Acta 1462, 71-87.
30. Wieprecht, T., Dathe, M., Krause, E., Beyermann, M., Maloy, W.L., MacDonald, D.L. & Bienert, M. (1997) Modulation of membrane activity of amphipathic, antibacterial peptides by slight modifications of the hydrophobic moment. FEBS Lett. 417, 135-140.
31. Giangaspero, A., Sandri, L. & Tossi, A. (2001) Amphipathic α-helical peptides. A systematic study of the effects of structural and physical properties on biological activity. Eur. J. Biochem 268, 5589-5600.
32. Kondejewski, L.H., Jelokhani-Niaraki, M., Farmer, S.W., Lix, B., Kay, C.M., Sykes, B.D., Hancock, R.E. & Hodges, R.S. (1999) Dissociation of antimicrobial and hemolytic activities in cyclic peptide diastereomers by systematic alterations in amphipathicity. J. Biol. Chem. 274, 13181-13192.
33. Chinchar, V.G., Wang, J., Murti, G., Carey, C. & Rollins-Smith, L. (2001) Inactivation of frog virus 3 and channel catfish virus by esculentin-2P and ranatuerin-2P, two antimicrobial peptides isolated from frog skin. Virology 288, 351-357.
34. Rollins-Smith, L.A., Carey, C., Longcore, J., Doersam, J.K., Boutte, A., Bruzgal, J.E. & Conlon, J.M. (2002) Activity of antimicrobial skin peptides from Ranid frogs against Batrachochytrium dendrobatidis, the chytrid fungus associated with global amphibian declines. Dev. Immunol. 26, 471-479.
35. Simmaco, M., Mignogna, G., Canofeni, S., Miele, R., Magnoni, M.L. & Barra, D. (1996) Temporins, antimicrobial peptides from the European red frog Rana temporaria. Eur. J. Biochem. 242, 788-792.
36. Case, S.M. (1978) Biochemical systematics of members of the genus Rana native to western North America. Syst. Zool. 27, 299-311.
37. Hillis, D.M. & Davis, S.K. (1986) Evolution of ribosomal DNA: fifty million years of recorded history in the frog genus Rana. Evolution 40, 1275-1288.
38. Farris, J.S., Kluge, A.G. & Mickevich, M.F. (1980) Paraphyly of the Rana boylii group. Syst. Zool. 28, 627-634.
39. Macey, J.R., Strasburg, J.L., Brisson, J.A., Vredenburg, V.T., Jennings, M. & Larson, A. (2001) Molecular phylogenies of western North American frogs of the Rana boylii species group. Mol. Phylogenet. Evol. 19, 131-143.